Activity of pivaloyloxymethyl butyrate, a novel anticancer agent, on primary human tumor colony-forming units
- 1 June 1998
- journal article
- Published by Springer Nature in Investigational New Drugs
- Vol. 16 (2) , 113-119
- https://doi.org/10.1023/a:1006049227744
Abstract
The anti-proliferative effects of pivaloyloxymethyl butyrate (AN-9), a butyric acid (BA) derivative with potent tumor-differentiating properties both in vitro and in vivo, was evaluated against...Keywords
This publication has 17 references indexed in Scilit:
- Effect of the cytostatic butyric acid pro-drug, pivaloyloxymethyl butyrate, on the tumorigenicity of cancer cellsZeitschrift für Krebsforschung und Klinische Onkologie, 1997
- Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cellsZeitschrift für Krebsforschung und Klinische Onkologie, 1997
- Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an HL‐60 leukemic cell lineInternational Journal of Cancer, 1994
- Rapid alteration of c‐myc and c‐jun expression in leukemic cells induced to differentiate by a butyric acid prodrugFEBS Letters, 1993
- Derivatives of butyric acid as potential anti‐neoplastic agentsInternational Journal of Cancer, 1991
- He's Not Going to Talk About In Vitro Predictive Assays Again, Is He?JNCI Journal of the National Cancer Institute, 1990
- Clinical pharmacology of sodium butyrate in patients with acute leukemiaEuropean Journal of Cancer and Clinical Oncology, 1987
- Biphasic Effect of Vanadium Salts on In Vitro Tumor Colony GrowthThe International Journal of Cell Cloning, 1987
- Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer DrugsNew England Journal of Medicine, 1978
- Primary Bioassay of Human Tumor Stem CellsScience, 1977